These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 32438207

  • 1. Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
    Baandrup L, Allerup P, Nielsen MØ, Bak N, Düring SW, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Kahn RS, Glenthøj BY.
    Psychiatry Res; 2020 Jul; 289():112970. PubMed ID: 32438207
    [Abstract] [Full Text] [Related]

  • 2. Item response analysis of the Positive and Negative Syndrome Scale.
    Santor DA, Ascher-Svanum H, Lindenmayer JP, Obenchain RL.
    BMC Psychiatry; 2007 Nov 15; 7():66. PubMed ID: 18005449
    [Abstract] [Full Text] [Related]

  • 3. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 15; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 4. Trajectories and antecedents of treatment response over time in early-episode psychosis.
    Levine SZ, Rabinowitz J.
    Schizophr Bull; 2010 May 15; 36(3):624-32. PubMed ID: 18849294
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of cariprazine in negative symptoms of schizophrenia: Post hoc analyses of PANSS individual items and PANSS-derived factors.
    Fleischhacker W, Galderisi S, Laszlovszky I, Szatmári B, Barabássy Á, Acsai K, Szalai E, Harsányi J, Earley W, Patel M, Németh G.
    Eur Psychiatry; 2019 May 15; 58():1-9. PubMed ID: 30738380
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J, Arango C, Garcia-Garcia M, Rejas J, CLAMORS Study Collaborative Group.
    J Clin Psychiatry; 2010 Mar 15; 71(3):280-6. PubMed ID: 19895779
    [Abstract] [Full Text] [Related]

  • 7. Scalability of the Positive and Negative Syndrome Scale in first-episode schizophrenia assessed by Rasch models.
    Baandrup L, Allerup P, Nielsen MØ, Düring SW, Bojesen KB, Leucht S, Galderisi S, Mucci A, Bucci P, Arango C, Díaz-Caneja CM, Dazzan P, McGuire P, Demjaha A, Ebdrup BH, Fleischhacker WW, Kahn RS, Glenthøj BY.
    Acta Psychiatr Scand; 2022 Jul 15; 146(1):21-35. PubMed ID: 35417039
    [Abstract] [Full Text] [Related]

  • 8. Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.
    Xu K, Krystal JH, Ning Y, Chen DC, He H, Wang D, Ke X, Zhang X, Ding Y, Liu Y, Gueorguieva R, Wang Z, Limoncelli D, Pietrzak RH, Petrakis IL, Zhang X, Fan N.
    J Psychiatr Res; 2015 Feb 15; 61():64-72. PubMed ID: 25560772
    [Abstract] [Full Text] [Related]

  • 9. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
    Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A, Gurvich C, Gilbert H, Berk M, Davis SR.
    JAMA Psychiatry; 2016 Sep 01; 73(9):947-54. PubMed ID: 27438995
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
    Volavka J, Czobor P, Derks EM, Bitter I, Libiger J, Kahn RS, Fleischhacker WW, EUFEST Study Group.
    J Clin Psychiatry; 2011 Jul 01; 72(7):955-61. PubMed ID: 21824456
    [Abstract] [Full Text] [Related]

  • 11. Symptom structure and severity: a comparison of responses to the positive and negative syndrome scale (PANSS) between patients with PTSD or schizophrenia.
    Stefanovics EA, Krystal JH, Rosenheck RA.
    Compr Psychiatry; 2014 May 01; 55(4):887-95. PubMed ID: 24602497
    [Abstract] [Full Text] [Related]

  • 12. Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS).
    Khan A, Lewis C, Lindenmayer JP.
    BMC Psychiatry; 2011 Nov 16; 11():178. PubMed ID: 22087503
    [Abstract] [Full Text] [Related]

  • 13. The heterogeneity of antipsychotic response in the treatment of schizophrenia.
    Case M, Stauffer VL, Ascher-Svanum H, Conley R, Kapur S, Kane JM, Kollack-Walker S, Jacob J, Kinon BJ.
    Psychol Med; 2011 Jun 16; 41(6):1291-300. PubMed ID: 20925971
    [Abstract] [Full Text] [Related]

  • 14. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS.
    Rabany L, Weiser M, Werbeloff N, Levkovitz Y.
    Schizophr Res; 2011 Mar 16; 126(1-3):226-30. PubMed ID: 21115328
    [Abstract] [Full Text] [Related]

  • 15. Choosing negative symptom instruments: issues of representation and redundancy.
    Welham J, Stedman T, Clair A.
    Psychiatry Res; 1999 Jul 30; 87(1):47-56. PubMed ID: 10512154
    [Abstract] [Full Text] [Related]

  • 16. Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia.
    Ruberg SJ, Chen L, Stauffer V, Ascher-Svanum H, Kollack-Walker S, Conley RR, Kane J, Kinon BJ.
    BMC Psychiatry; 2011 Feb 09; 11():23. PubMed ID: 21306626
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct 09; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 18. PANSS-6: a brief rating scale for the measurement of severity in schizophrenia.
    Østergaard SD, Lemming OM, Mors O, Correll CU, Bech P.
    Acta Psychiatr Scand; 2016 Jun 09; 133(6):436-44. PubMed ID: 26558537
    [Abstract] [Full Text] [Related]

  • 19. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA, Oosthuizen PP, Joubert AF, Roberts MC, Stein DJ.
    J Clin Psychiatry; 1999 Nov 09; 60(11):747-51. PubMed ID: 10584762
    [Abstract] [Full Text] [Related]

  • 20. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP, Brown E, Baker RW, Schuh LM, Shao L, Tohen M, Ahmed S, Stauffer VL.
    Schizophr Res; 2004 Jun 01; 68(2-3):331-7. PubMed ID: 15099614
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.